4.8 Article

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1

期刊

NATURE CELL BIOLOGY
卷 16, 期 11, 页码 1092-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb3050

关键词

-

资金

  1. Ludwig Institute for Cancer Research Ltd
  2. International Cooperation and Exchange Project of the National Natural Science Foundation of China
  3. National Basic Research Program of China (973 Program) [2010CB945600, 2010CB833600]
  4. Medical Research Council [MR/J000930/1]
  5. Cancer Research UK [C5255/A12678]
  6. MRC [MR/J000930/1] Funding Source: UKRI
  7. Cancer Research UK [16945, 15680, 16466] Funding Source: researchfish
  8. Medical Research Council [MR/J000930/1] Funding Source: researchfish

向作者/读者索取更多资源

Epithelial to mesenchymal transition (EMT), and the reverse mesenchymal to epithelial transition (MET), are known examples of epithelial plasticity that are important in kidney development and cancer metastasis. Here we identify ASPP2, a haploinsufficient tumour suppressor, p53 activator and PAR3 binding partner, as a molecular switch of MET and EMT. ASPP2 contributes to MET in mouse kidney in vivo. Mechanistically, ASPP2 induces MET through its PAR3-binding amino-terminus, independently of p53 binding. ASPP2 prevents beta-catenin from transactivating ZEB1, directly by forming an ASPP2-beta-catenin-E-cadherin ternary complex and indirectly by inhibiting beta-catenin's N-terminal phosphorylation to stabilize the beta-catenin-E-cadherin complex. ASPP2 limits the pro-invasive property of oncogenic RAS and inhibits tumour metastasis in vivo. Reduced ASPP2 expression results in EMT, and is associated with poor survival in hepatocellular carcinoma and breast cancer patients. Hence, ASPP2 is a key regulator of epithelial plasticity that connects cell polarity to the suppression of WNT signalling, EMT and tumour metastasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification Using Rapid Evaporative Ionization Mass Spectrometry

Sam E. Mason, Eftychios Manoli, James L. Alexander, Liam Poynter, Lauren Ford, Petra Paizs, Afeez Adebesin, James S. McKenzie, Francesca Rosini, Rob Goldin, Ara Darzi, Zoltan Takats, James M. Kinross

Summary: This study used REIMS to analyze the lipid composition of colorectal tissues and evaluate its accuracy for real-time tissue recognition and risk stratification. The results showed that REIMS can differentiate samples of carcinoma, adenoma, and normal mucosa with 93.1% accuracy and 96.1% negative predictive value for carcinoma. It can also predict the presence of neoplasia (carcinoma or adenoma) with 96.0% accuracy and 91.8% negative predictive value. In addition, the study identified unique lipidomic features associated with colorectal carcinogenesis, such as the progressive increase in relative abundance of phosphatidylglycerols, sphingomyelins, and monounsaturated fatty acid-containing phospholipids.

ANNALS OF SURGERY (2023)

Article Biochemistry & Molecular Biology

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease

Naila Rabbani, Antonysunil Adaikalakoteswari, James R. R. Larkin, Sianna Panagiotopoulos, Richard J. J. MacIsaac, Dennis K. K. Yue, Gregory R. R. Fulcher, Matthew A. A. Roberts, Merlin A. Thomas, Elif Ekinci, Paul J. J. Thornalley

Summary: Accumulation of advanced glycation endproducts (AGEs) is associated with decline in renal function, particularly in diabetic patients. This study evaluated levels of AGEs in subjects with and without diabetes, with normal renal function and stages 2-4 chronic kidney disease (CKD), and identified a specific AGE, methylglyoxal-derived hydroimidazolone (MG-H1) free adduct, as the most responsive to CKD status and diabetes. The concentration of MG-H1 free adduct in serum was strongly related to CKD stage and increased in diabetes. This suggests that serum MG-H1 free adduct may serve as a potential AGE risk marker for diabetic and non-diabetic CKD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pathology

Survey of liver pathologists to assess attitudes towards digital pathology and artificial intelligence

Clare McGenity, Rebecca Randell, Christopher Bellamy, Alastair Burt, Alyn Cratchley, Robert Goldin, Stefan G. Hubscher, Desley A. H. Neil, Alberto Quaglia, Dina Tiniakos, Judy Wyatt, Darren Treanor

Summary: This study surveyed members of the UK Liver Pathology Group to understand their attitudes and priorities towards digital pathology and artificial intelligence in liver disease. The majority of liver pathologists in the UK are in favor of using digital pathology and AI in clinical practice, research, and education.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Biochemical Research Methods

Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice

May Zaw Thin, Christopher Moore, Thomas Snoeks, Tammy Kalber, Julian Downward, Axel Behrens

Summary: In this paper, a method of lung nodule image acquisition and analysis using a micro-computed tomography scanner is introduced for translational research in lung cancer that closely mimics clinical environments. The method has the advantages of low radiation dose, high resolution, and high-throughput imaging, and utilizes specific image analysis tools for identifying different types of lung tumors.

NATURE PROTOCOLS (2023)

Article Cell Biology

Regulation of immunological tolerance by the p53-inhibitor iASPP

Elliot H. H. Akama-Garren, Paul Miller, Thomas M. M. Carroll, Michael Tellier, Gopinath Sutendra, Ludovico Buti, Justyna Zaborowska, Robert D. D. Goldin, Elizabeth Slee, Francis G. G. Szele, Shona Murphy, Xin Lu

Summary: Maintaining a balance between tolerance and autoimmunity is crucial for preventing human diseases. The protein p53 and its regulator iASPP play important roles in immunological tolerance and tumorigenesis. Deficiency in iASPP promotes tumor development but reduces susceptibility to autoimmune diseases. Furthermore, iASPP-deficient tumors exhibit immunosuppression characteristics, suggesting potential therapeutic opportunities for targeting the iASPP/p53 axis in autoimmune diseases and cancer.

CELL DEATH & DISEASE (2023)

Article Gastroenterology & Hepatology

Rationalising the use of specimen pots following colorectal polypectomy: a small step towards greener endoscopy

Karl King Yong, Yun He, Hoi Ching Annie Cheung, Ramya Sriskandarajah, William Jenkins, Robert Goldin, Sabina Beg

Summary: This study aimed to determine if combining multiple small colorectal polyps in a single specimen pot can reduce carbon footprint without negatively impacting clinical outcomes. Results showed that consolidating small polyps could decrease carbon footprint, but may also result in missing advanced lesions. Therefore, changing practice at a national level could amplify the reduction in carbon footprint from judicious use of specimen pots.

FRONTLINE GASTROENTEROLOGY (2023)

Review Biochemistry & Molecular Biology

Synthetic lethal approaches to target cancers with loss of PTEN function

Ayse Ertay, Rob M. Ewing, Yihua Wang

Summary: PTEN is a tumor suppressor gene that inhibits the oncogenic AKT signaling pathway by dephosphorylating PIP3 into PIP2. Inactive PTEN is associated with aggressive tumor phenotype and tumorigenesis. Identifying targeted therapies for inactive tumor suppressor genes like PTEN is challenging, thus synthetic lethality studies targeting downstream signaling pathways have gained importance. This review focuses on potential synthetic lethality genes discovered in PTEN-inactive cancer types, which could serve as targeted therapies and improve response rates for aggressive types of cancer.

GENES & DISEASES (2023)

Article Biochemistry & Molecular Biology

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer

Paul Miller, Elliot H. Akama-Garren, Richard P. Owen, Constantinos Demetriou, Thomas M. Carroll, Elizabeth Slee, Khatoun Al Moussawi, Michael Ellis, Robert Goldin, Eric O'Neill, Xin Lu

Summary: iASPP is an inhibitor of p53 that suppresses inflammation and oncogenic KRAS-driven pancreatic cancer tumorigenesis.

CELL DEATH AND DIFFERENTIATION (2023)

Article Biochemistry & Molecular Biology

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin H. Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D. Goldin, Mark R. Thursz, Pinelopi Manousou

Summary: Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide, and fibrosis stage is an important predictor for clinical outcomes. This study investigates the metabolic profile of NAFLD patients in relation to fibrosis progression. The results show that a combination of metabolites and lipoproteins can accurately identify fast fibrosis progressors and perform better than noninvasive markers. These specific metabolic profiles can predict fibrosis progression in patients with NAFLD, and algorithms combining metabolites and lipids could be used for risk stratification of these patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis

Emma Rose McGlone, Matthieu Siebert, Marian Dore, David C. D. Hope, Iona Davies, Bryn Owen, Bernard Khoo, Rob Goldin, Dave Carling, Stephen Bloom, Maude Le Gall, Tricia M-M. Tan

Summary: The study investigated the effects of sleeve gastrectomy on weight-independent improvements in liver steatosis in mice with diet-induced obesity. It was found that VSG not only improves liver fat content but also enhances insulin and glucagon sensitivity.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

Diego Calvisi, Luke Boulter, Javier Vaquero, Anna Saborowski, Luca M. Fabris, Pedro Rodrigues, Cedric E. Coulouarn, Rui Castro, Oreste Segatto, Chiara Raggi, Luc J. W. van der Laan, Guido Carpino, Benjamin Goeppert, Stephanie J. Roessler, Timothy Kendall, Matthias Evert, Ester W. Gonzalez-Sanchez, Juan Valle, Arndt Vogel, John J. Bridgewater, Mitesh J. Borad, Gregory R. Gores, Lewis Roberts, Jose J. G. B. Marin, Jesper Andersen, Domenico Alvaro, Alejandro M. Forner, Jesus Banales, Vincenzo Cardinale, Rocio I. R. Macias, Silve Vicent, Xin Chen, Chiara Braconi, Monique M. A. Verstegen, Laura Fouassier, Lewis Roberts, Alexander Scheiter, Florin M. Selaru, Katja Evert, Kirsten Utpatel, Laura Broutier, Massimiliano Cadamuro, Meritxell Huch, Robert Goldin, Sergio A. Gradilone, Yoshimasa Saito

Summary: In this Consensus Statement, experts provide recommendations on the criteria for preclinical models of cholangiocarcinoma (CCA) to increase disease understanding and develop novel therapeutic approaches.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Integrated analysis reveals the protective mechanism and therapeutic potential of hyperbaric oxygen against pulmonary fibrosis

Yuan Yuan, Guoqiang Qiao, Jiajiao Zhou, Yilu Zhou, Yali Li, Xia Li, Zhenglin Jiang, Yihua Wang

Summary: This study investigated the protective mechanism of repetitive hyperbaric oxygen (HBO) treatment against pulmonary fibrosis. By analyzing expression data from mouse models and IPF patients, potential mechanisms related to IPF pathology, including epithelial-to-mesenchymal transition (EMT) and glycolysis, were identified. High EMT or glycolysis scores were strong independent predictors of mortality. These processes were potentially driven by hypoxia and blocked by HBO treatment. These data support HBO treatment as a viable strategy against pulmonary fibrosis.

GENES & DISEASES (2023)

Article Multidisciplinary Sciences

Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis

Jonathan W. Lo, Domenico Cozzetto, James L. Alexander, Nathan P. Danckert, Matthew Madgwick, Naomi Knox, Jillian Yong Xin Sieh, Marton Olbei, Zhigang Liu, Hajir Ibraheim, Jesus Miguens Blanco, Hiromi Kudo, Rocio Castro Seoane, Lucia A. Possamai, Robert Goldin, Julian Marchesi, Tamas Korcsmaros, Graham M. Lord, Nick Powell

Summary: Immune checkpoint inhibitors (CPIs) are a new cancer treatment that can potentially cure previously untreatable diseases. However, they can also cause off-target immune-mediated tissue injury. Researchers found that CPI-colitis in mice depends on the composition of the intestinal microbiota and the expression of certain immune molecules. Targeting these factors may hold the key to reversing CPI-colitis.

NATURE COMMUNICATIONS (2023)

Editorial Material Biochemistry & Molecular Biology

Impact of the COVID-19 pandemic on lung cancer treatment and research

Shreya Kailas Lovlekar, Yihua Wang

GENES & DISEASES (2023)

Article Gastroenterology & Hepatology

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

David J. Pinato, Takahiro Kaneko, Antonio D'Alessio, Alejandro Forner, Petros Fessas, Beatriz Minguez, Edoardo G. Giannini, Federica Grillo, Alba Diaz, Francesco A. Mauri, Claudia A. M. Fulgenzi, Alessia Dalla Pria, Robert D. Goldin, Giulia Pieri, Pierluigi Toniutto, Claudio Avellini, Maria Corina Plaz Torres, Ayse U. Akarca, Teresa Marafioti, Sherrie Bhoori, Jose Maria Miro, Mark Bower, Norbert Brau, Vincenzo Mazzaferro

Summary: The aim of this study was to evaluate the impact of HIV infection on the functional characteristics of T cell infiltrate in hepatocellular carcinoma (HCC). Results showed that HIV infection was associated with increased immune exhaustion and higher expression of PD-L1 in tumor tissue. Therefore, prospective testing of immunotherapy in HIV-associated HCC is warranted.

JHEP REPORTS (2023)

暂无数据